What Are the Side Effects of Lidocaine Patches?

Lidocaine patches produce mostly mild, localized skin reactions, and serious side effects are uncommon. Reviews of the clinical evidence consistently describe them as well tolerated, with minimal drug entering the bloodstream under normal conditions. That reassuring profile is a big part of why they are so widely prescribed for nerve-related pain. But “generally safe” is not the same as “nothing to worry about,” and the handful of situations where problems do arise are worth understanding.

Skin Reactions Are the Most Common Side Effect

The side effect you are most likely to notice is some kind of skin response at the spot where the patch sits. Redness, mild irritation, a slight rash, or itchiness under or around the patch are all reported frequently. In an open-label study of patients using lidocaine patches for low back pain, rash and dizziness were the most common adverse events, each occurring in about 4% of participants, and the large majority of all reported side effects were mild to moderate.¹ Most of these skin reactions are simple contact irritation from the adhesive or the patch material itself, not a true drug allergy, and they tend to resolve once the patch is removed.

There is, however, a meaningful distinction between garden-variety irritation and allergic contact dermatitis. Irritation happens because skin does not love having adhesive stuck to it for twelve hours. Allergic contact dermatitis, by contrast, is an immune-mediated reaction to the lidocaine molecule itself. A review of patch-testing data found that contact allergy to local anesthetics occurs at a rate of about 2.4%, with lidocaine accounting for roughly a third of those cases.² The practical difference matters. If you have simple irritation, rotating the patch site and using a skin barrier product often solves the problem. If you develop a true allergy to lidocaine, you need to stop using the patch and alert your healthcare provider, because the same allergy could affect you during dental procedures or minor surgeries where lidocaine injections are standard. One reassuring detail: because allergic contact dermatitis is a delayed-type immune reaction limited to the skin, it does not carry a risk of anaphylaxis the way some drug allergies do.²

How Much Lidocaine Actually Enters Your Bloodstream

One reason lidocaine patches have such a mild side-effect profile is that very little of the drug makes it past the skin and into your circulation. Pharmacokinetic studies looking at 12-, 18-, and even 24-hour daily use have consistently found that plasma concentrations stay far below the levels associated with systemic toxicity or meaningful drug interactions.³ In a controlled trial of patients with postherpetic neuralgia, the highest blood lidocaine level measured after 12 hours of patch use was 0.1 micrograms per milliliter, which the researchers noted indicated minimal systemic absorption.⁴ For context, the blood levels at which lidocaine starts causing neurological symptoms like dizziness, numbness around the mouth, or ringing in the ears are many times higher than what a patch delivers.

This is the core safety advantage of the patch form. When lidocaine is injected or sprayed onto mucous membranes, blood levels rise quickly and can reach problematic concentrations if the dose is not carefully controlled. A patch delivers the drug slowly through intact skin, creating a kind of built-in speed limit on absorption. The drug accumulates in the tissue directly beneath the patch and works on the local nerve fibers there without flooding the rest of your body.

Why Heat Changes the Equation

One situation where that built-in speed limit can be overridden is exposure to heat. Warming the skin increases blood flow to the area and opens up the barrier properties of the outer skin layers, allowing more lidocaine to cross into the bloodstream than the patch was designed to deliver. A crossover study in healthy volunteers found that applying external heat to the patch area raised peak blood lidocaine levels by about 60% compared to normal conditions.⁵ A separate study using a lidocaine-containing patch found the effect was even more dramatic in the first hour: plasma concentrations were roughly five times higher after 30 minutes and three times higher after 60 minutes when a heated patch was compared to an unheated one.⁶

The good news is that levels returned toward normal within a few hours once the heat source was removed.⁵ Even so, the spike matters. This is why prescribing information for lidocaine patches warns against using heating pads, electric blankets, heated waterbeds, or prolonged hot baths or saunas while wearing the patch. If you exercise vigorously enough to substantially raise your skin temperature, the same principle applies, though to a lesser degree than direct applied heat. It is one of those warnings that sounds overly cautious until you see how sharply the absorption curve shifts.

Rare but Serious Reactions

With patches used as directed, serious systemic side effects are genuinely rare. But they are not impossible, and knowing what to watch for is worthwhile because some of these reactions require immediate treatment.

Lidocaine in any form can, at high enough doses, affect the heart and the central nervous system. When blood levels climb above the therapeutic window, early warning signs include dizziness, lightheadedness, drowsiness, and a metallic taste in the mouth. At much higher concentrations, more dangerous effects can follow, including seizures, heart rhythm disturbances, and in extreme cases, cardiovascular collapse.⁷ A case series examining acute lidocaine toxicity events found that the most frequent presentations were nausea and vomiting, seizures, and loss of consciousness.⁸ These were not patch-related cases, and reaching such levels from properly applied patches is extraordinarily unlikely. They illustrate what lidocaine toxicity looks like in general, which helps explain why proper patch use guidelines exist.

Another rare reaction worth knowing about is methemoglobinemia, a condition where lidocaine changes the structure of hemoglobin so it cannot carry oxygen effectively. A documented case involving topical lidocaine found that a patient’s methemoglobin level climbed to 53%, causing dangerously low oxygen saturation, though the condition responded well to treatment with an intravenous antidote.⁹ This particular case involved a form of topical lidocaine other than patches, and the risk with patches at standard doses is extremely low. Still, if you notice bluish discoloration of your lips, nailbeds, or skin while using any lidocaine product, that is a reason to seek emergency care. People who take certain other medications that can independently cause methemoglobinemia, such as some antibiotics and nitrates, may face a slightly elevated risk when using lidocaine patches concurrently.

Who Needs Extra Caution

Lidocaine patches are processed primarily by the liver, so people with significant liver disease may clear the drug more slowly and accumulate higher blood levels than expected. The same concern applies to anyone whose liver metabolism is compromised, whether from illness, aging, or other medications competing for the same liver enzymes. For most healthy adults, the tiny amount of lidocaine absorbed from a patch is well within the liver’s capacity to handle. But the margin of safety narrows when liver function is reduced.

Kidney disease presents its own set of considerations. A 2017 review on pain management in chronic kidney disease supported the use of topical lidocaine for localized pain but specifically cautioned that prolonged or high-dose use requires vigilance because of skin absorption and the potential for systemic accumulation.¹⁰ This does not mean patients with kidney disease cannot use lidocaine patches, but it does mean sticking carefully to the prescribed schedule and not layering on extra patches or leaving them on longer than directed.

Older adults deserve particular mention. Age-related changes in skin permeability, liver function, and body composition can all nudge the risk profile higher. A case report described an elderly patient who developed delirium associated with lidocaine patch use, a side effect that most clinicians would not immediately connect to a topical pain patch.¹¹ Delirium in older patients often has multiple contributing causes, and a lidocaine patch may not be the sole trigger. But if an older person begins showing confusion, agitation, or altered consciousness after starting lidocaine patches, the patch should be considered as a possible contributor rather than dismissed because it is “just topical.”

Drug Interactions

Because so little lidocaine enters the bloodstream from a patch, the risk of drug interactions is substantially lower than with oral or injected forms. A narrative review examining the use of lidocaine patches alongside systemic gabapentinoids found that the combination had a more tolerable safety profile, partly because the patches did not produce meaningful drug-drug interactions with the systemic medications.¹² This is a practical advantage for people managing chronic pain, who are often taking multiple medications simultaneously.

That said, the interaction risk is low rather than zero. If you are already receiving lidocaine from another source, such as an infusion for arrhythmia management, the cumulative dose matters. Other local anesthetics applied topically to the same general area could theoretically add to the local and systemic lidocaine load. And the class of heart medications known as antiarrhythmics, particularly other sodium-channel blockers, could have additive effects with lidocaine on cardiac conduction. Your pharmacist or prescriber should be checking for these scenarios, but it is worth mentioning if you are using lidocaine patches alongside any heart rhythm medications.

What Happens When Patches Are Misused

Most of the serious side effects associated with lidocaine patches in real-world use come not from the drug being inherently dangerous but from the patches being used incorrectly. The labeling for the prescription-strength 5% patch specifies a maximum of three patches applied simultaneously, worn for up to 12 hours followed by a 12-hour patch-free period. People sometimes apply more patches than prescribed, leave them on around the clock, apply them to broken or inflamed skin that absorbs the drug much faster, or cut the patches to fit awkwardly shaped areas without realizing that a cut edge can release lidocaine more rapidly.

The case series on acute lidocaine toxicity mentioned earlier found that a substantial proportion of severe toxicity cases resulted in intensive care admissions, with some patients experiencing status epilepticus leading to cardiac arrest.⁸ Those cases involved intentional overdoses rather than patch misuse, but they underscore that lidocaine is a real drug with a real toxicity threshold, even though the patch formulation is designed to keep you safely below it. Applying patches to large areas of damaged skin, stacking more than the recommended number, or wearing them continuously without a break can all push blood levels into the range where those early warning symptoms of toxicity appear.

Used patches also retain a significant amount of lidocaine after removal. A used patch is not inert. If a child or pet were to chew on a discarded patch, they could absorb enough lidocaine to cause serious harm. Proper disposal means folding the patch in half with the sticky sides together so it cannot accidentally adhere to skin, and throwing it away where it is not accessible to children or animals. Some pharmacies accept used patches for safe disposal alongside other medications.

The Broken-Skin Problem

Lidocaine patches are meant to be applied to intact skin. This point shows up in every prescribing guide, but it is easy to overlook because the areas where people want pain relief are often the same areas where skin integrity is compromised. Post-surgical incisions, rashes from shingles that have not fully healed, eczema flares, and sunburned skin all increase the rate at which lidocaine crosses into the body. The patch’s safety margin depends on the skin acting as a controlled barrier. When that barrier is disrupted, the slow-release design partially breaks down, and blood levels can rise higher and faster than expected.

This is especially relevant for people using lidocaine patches for postherpetic neuralgia, the condition for which the 5% patch was originally approved. The painful skin in postherpetic neuralgia is often hypersensitive but may also still have residual damage from the shingles rash. Clinicians generally advise waiting until active blisters have fully crusted and healed before applying the patch. In practice, this means some patients have to endure a period of pain without the patch while their skin recovers enough to use it safely.

Tolerance, Dependence, and Long-Term Use

One of the more common questions about any pain medication is whether it stops working over time or causes dependence. Lidocaine is not an opioid and does not act on the brain’s reward pathways, so physical dependence and addiction are not concerns. You will not develop cravings or withdrawal symptoms if you stop using the patches.

The question of tolerance, meaning whether the patch becomes less effective over months or years of use, is harder to answer with certainty because long-term studies specifically tracking this are limited. The mechanism of action, blocking sodium channels in local nerve fibers, is not one that typically produces tolerance the way opioid receptors downregulate with chronic stimulation. Clinically, many patients use lidocaine patches for extended periods without reporting a significant decline in effectiveness. If the patches seem to be losing their effect, it is more likely that the underlying pain condition has progressed than that your nerves have adapted to the lidocaine.

Long-term skin health at the application site is a more practical concern. Repeatedly applying adhesive patches to the same area can cause chronic irritation, thinning of the outer skin layer, or contact sensitization that develops gradually over months of use. Rotating the patch site within the painful area, when possible, and giving skin a full 12 hours of recovery between applications both help minimize cumulative skin damage.

Children, Pregnancy, and Breastfeeding

Lidocaine patches are approved for adult use, and there is limited clinical trial data on their safety in children. Pediatric skin is thinner and more permeable than adult skin, which means the same patch could produce proportionally higher blood levels in a smaller person. Off-label use in children does occur under medical supervision, but the dosing and monitoring need to be carefully adjusted. The risk of accidental exposure is also higher in households with children, both from unused patches left within reach and from used patches discarded without adequate precaution.

For pregnancy, lidocaine is generally considered compatible with use when the benefit justifies it, as the systemic absorption from patches is minimal. However, formal safety studies in pregnant women are lacking, and most guidelines recommend discussing the risks and benefits with a healthcare provider rather than assuming safety. Lidocaine does pass into breast milk in small amounts, but the quantity absorbed from a patch is low enough that most sources consider it unlikely to affect a nursing infant. As with pregnancy, though, the formal evidence base is thin, and the default advice is to consult your prescriber.